Relationship of metabolic markers in Parkinson’s disease
Objective: To investigate the relationship of obesity, Hypertension (HTN), Ischemic heart disease (IHD), Dyslipidemia (DLP), and Diabetes Mellitus (DM) with PD. Background: Parkinson’s disease (PD)…Eight contact LFP recordings in the Subthalamic region localize beta source to the dorsal STN
Objective: The aim of this study was to investigate the electrophysiological characteristics of intra and extra STN LFPs in PD to better locate the source…Psycho-behavioral profile of Parkinson’s disease patients with RLS: a cross sectional-study
Objective: To determine whether RLS could be associated with a specific psycho-behavioral profile and ICDs in Parkinson's disease (PD). Background: Impulse Control Disorders (ICDs) have…Patients’ Perspective of Physicians’ Counseling on Exercise in Parkinson’s Disease (PD)
Objective: To assess if exercise counseling during appointments translates to knowledge or action in PD patients Background: Aerobic activity can improve motor function, mood, cognition,…How Usual Is Skin Rashes During Treatment With Levodopa / Benserazide Hydrochloride?
Objective: To clarify the possible associations of levodopa / benserazidehydrochloride usage and skin rashes. Background: Levodopa/benserazide hydrochloride is one of the best dopaminergic drug used…PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins
Objective: To study selective regional binding for tau pathology in vivo, using PET with [11C]PBB3 ([11C]methylamino pyridin-3-yl buta-1,3-dienyl benzo[d]thiazol-6-ol) in tauopathies, and in conditions not…Multimodal biomarkers as predictors of cognitive decline in Parkinson’s Disease
Objective: To identify a set of multimodal biomarkers to predict cognitive decline in non-demented Parkinson’s disease patients. Background: People with Parkinson’s Disease are at high…Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease
Objective: To compare the non-motor symptom assessment scale (NMSS) score between Leucine-rich repeat kinase 2 (LRRK2) mutation carriers with Parkinson disease (PD) and matched controls with…Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients
Objective: We aim to estimate the frequency of mutations in the glucocerebrosidase gene (GBA) and LRRK2 G2019S in a yet unstudied Egyptian Parkinson's disease population from the…Pure ATXN10 repeat expansion causes Parkinson’s disease
Objective: Clinical and genetic characterization of a multigenerational family with spinocerebellar ataxia type 10 (SCA10) and parkinsonism. Background: Pentanucleotide repeat expansions of ATTCT in intron…
- « Previous Page
- 1
- …
- 334
- 335
- 336
- 337
- 338
- …
- 425
- Next Page »